Living up to 100 years of Bayer Healthcare cardiovascular protection - Bayer Healthcare Cardiovascular : 20 years of participation in the South African cardiovascular community.
D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001241:Aspirin / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000209:etiology / Q000517:prevention & control*; D004304:Dosage Forms; D004345:Drug Industry; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy*; D009543:Nifedipine / Q000627:therapeutic use; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D018570:Risk Assessment; D013019:South Africa; D016896:Treatment Outcome
D000959:Antihypertensive Agents; D002121:Calcium Channel Blockers; D004304:Dosage Forms; D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors; D009543:Nifedipine; D001241:Aspirin